Bone Metastasis
Cancer
Bone Metastasis is treated with 6 medications in our database, including Zoledronic acid, XGEVA, Hemady, Technescan HDP, Sodium Fluoride F18, and 1 more. 5 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., Amgen, Edenbridge, Curium. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Bone Metastasis treatment below.
What help exists for Bone Metastasis
12
drugs indexed
8
with copay cards
8
with patient assistance
0
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Bone Metastasis
12 totalXTRENBO
Denosumab-qbde
Sodium Fluoride F18
Sodium Fluoride F18 · PETNET Solutions, Inc.
Osenvelt
denosumab-bmwo
🎟💙Bilprevda
Denosumab · Janssen Biotech, Inc.
🎟💙XGEVA
denosumab · Amgen
🎟💙Oziltus
denosumab-mobz
WYOST
denosumab · Sandoz
🎟💙Zoledronic Acid
Zoledronic Acid
🎟💙Technescan HDP
Technetium Tc 99m Oxidronate · Curium
Hemady
dexamethasone · Edenbridge
🎟💙AUKELSO
Denosumab-kyqq
🎟💙BOMYNTRA
Denosumab · Alnylam Pharmaceuticals
🎟💙
🎟 = copay card · 💙 = patient assistance program
Prior authorization patterns for Bone Metastasis drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | Yes | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | Yes | — | — |
— Medicare Part D | Yes | — | — |
— Medicare Part D | Yes | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | Yes | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
Showing 10 of 14 PA rules for Bone Metastasis drugs. View individual drug pages for complete PA detail.